Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...

Anakinra (Kineret), an antagonist of the interleukin-1 receptor, recently was FDA approved for treatment of rheumatoid arthritis (RA). In this manufacturer-sponsored, double-blind, randomized ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head off the progression of inflammation through trial-and-error treatment with a ...

A study from Spain found a subcutaneous tocilizumab biosimilar to be cost-effective when treating patients with rheumatoid ...

A new clinical study highlighted the potential of ivarmacitinib, a selective Janus kinase (JAK) 1 inhibitor, as an effective ...

This year the biosimilars to Stelara (ustekinumab) stand to be the stars of the biosimilars show. The FDA has approved seven ...

CALIFORNIA, CA, UNITED STATES, January 22, 2025 /EINPresswire / -- "Cutting-Edge Solutions Enabling Businesses to Make Smarter Decisions" A new Report by Exactitude Consultancy, titled ...